Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share
16/10/2024 10:53
Oct 16 (Reuters) - APONTIS PHARMA AG APPHG.DE :
* APONTIS PHARMA AND ZENTIVA ENTER INTO INVESTMENT AGREEMENT
–
ZENTIVA WILL LAUNCH A VOLUNTARY PUBLIC PURCHASE OFFER
* ZENTIVA TO LAUNCH VOLUNTARY PUBLIC PURCHASE OFFER AT EUR
10.00
PER SHARE
* OFFER SUBJECT TO REGULATORY APPROVALS AND 65% MINIMUM
ACCEPTANCE
THRESHOLD
* EXECUTIVE BOARD AND SUPERVISORY BOARD OF APONTIS PHARMA
WELCOME
AND SUPPORT OFFER
Source text for Eikon: ID:nEQBbSdZa
Further company coverage: APPHG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share